Global lactoferrin market is anticipated to witness growth owing to increasing prevalence of diseases such as diarrhea, stomach/intestinal ulcers and hepatitis-C coupled with varying preferences of healthcare practitioners for protein drugs. Lactoferrin is a protein found in cow milk and human milk. Studies suggest that lactoferrin is efficient in boosting immunity and preventing iron deficiency and cancer. Rising government funding for protein engineering, reduction in cost of drug delivery and increasing geriatric population base is further expected to drastically drive the lactoferrin market. The unique properties such as antimicrobial, immunomodulatory, antineoplastic makes lactoferrin ideally suited for many medicines. Furthermore, rapidly increasing incidences of lifestyle disease coupled with viral infections are also propelling global lactoferrin market.
The market on the basis of lactoferrin use is segmented as antibacterial, anti-inflammatory, anti-oxidant, immunomodulatory and as a diet supplement. Its application in wide range of industries including infant food, pharmaceuticals, personal care products and veterinary and feed specialties is further fuelling its market demand. Lactoferrin is also popular as a food supplement with endurance athletes such as cyclists and runners. Its ability to bind iron on blood vessels suggests that it can reduce Alzheimer’s disease, cancer or heart disease. Lactoferrin is a safe nutritional supplement without any adverse effects. Biotechnology and pharmaceutical companies segment are anticipated to be the largest consumer of this market. The growth of pharmaceutical companies and biotechnology is attributed to rising R & D budgets and technological advancements in pharmaceutical sector.
Emerging studies on lactoferrin suggest that it can help fight obesity by inhibiting accumulation of fat in cells. The use of lactoferrin reduces the risk of metabolic endotoxemia which produces inflammation and destroys the organs. Research also suggests that lactoferrin helps reduce osteoporosis and helps control blood sugar levels further opening avenues for market development of lactoferrin. Higher levels of lactoferrin in blood are associated with lower blood sugar levels and higher insulin sensitivity.
Market for lactoferrin is limited to few regions of Asia pacific which include China and Japan. Increasing healthcare expenditure and presence of protein-based drug manufacturers are key drivers for lactoferrin market in these regions. Europe is anticipated to witness steady growth owing to rigorous marketing and communication strategies on lactoferrin. In Japan the market initially started with infant food and is progressing towards dairy foods and various food supplements.
Major players operating in the global lactoferrin market include Alcon Laboratories, Metagenics, Vida Nutriscience, MP Biomedicals, Symbiotics, Prohealth Inc. Synlait Milk is investing USD 15 million to manufacture lactoferrin as a spray dried powder. The global shortage for lactoferrin driven by high demand for infant food is further anticipated to fuel the market demand for this protein over the forecast period.
Avail customized purchase options to meet your research needs:
Get your queries resolved from an industry expert. Request for a free product review before report purchase.
Speak to the report author to design an exclusive study to serve your research needs.
A testimonial for service excellence represented in the form of BBB "A" Accreditation.
Your personal and confidential information is safe and secure.